ResMed Inc (RMD)
NASDAQ • Healthcare
January 21, 2026 at 21:00 UTC
Name
CEO
Website
Industry
Year Founded
Employees
ResMed Inc is a medical technology company focused on sleep and respiratory care, pairing devices and software with programs that help patients stay on therapy. The business works where home care meets clinical oversight: equipment is designed for comfort and consistency, data flows to caregivers through secure channels, and support helps people manage therapy without turning it into a project. Providers use connected workflows to onboard patients, monitor adherence, and coordinate service visits in measured steps rather than emergency bursts. The operating principle is calm reliability — make equipment easy to live with, keep information clear for clinicians, and resolve issues quickly. Within healthcare, ResMed occupies the connective layer between prescription and daily use, helping long-term therapies fit ordinary routines.
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
ResMed Inc's Technical Indicators Summary
RMD is exhibiting a generally bullish trend as its price comfortably sits above most key moving averages, including the 200-day SMA, which signals sustained upward momentum. Momentum indicators such as the CCI and MACD support this positive bias, while the RSI suggests a balanced condition without overextension. The ADX value indicates a moderate trend strength, pointing to a steady but not overly strong directional move. Although the ATR shows average volatility, the rising On-Balance Volume underlines buying interest despite the session being closed. Overall, the technical signals highlight a constructive environment with room for further consolidation near current levels. The current technical landscape favors continued bullishness with measured momentum.
| Indicator | Value |
|---|---|
RSI (14) | 59.53 |
Stochastic %K (14, 3, 3) | 84.23 |
CCI (20) | 134.08 |
WPR (14) | -23.13 |
Momentum (10) | 12.77 |
MFI | 75.25 |
MACD Level (12, 26) | 2.34 |
Bollinger Bands | $236.33 - $261.27 |
ATR (14) | $5.46 (2.12%) |
ADX (14) | 23.45 |
OBV | -5,814,200 |
Simple Moving Averages | $248.80 - $259.99(5 indicators) |
Exponential Moving Averages | $250.96 - $255.31(5 indicators) |
Get premium market insights delivered directly to your inbox.
Into the close, RMD still reflected its 2.409% upside gap from yesterday, finishing near 259.29. By the close, RMD faced an extremely defensive options stance, with a high PCR of 1.72. ResMed's stock remains resilient amid institutional interest and a cautious options stance.
Price Change
from $253.19 close
+$6.1
Trading Volume
Below avg (898.9K)
550K
vs S&P 500 Today
Strong Outperformance
+4.91%
52-Week Position
Mid-range
63.2%
Updated: January 21, 2026 at 21:03 UTC
2025 Valuation Insights: Spotify, Aker BP, and Key Growth Stocks
December 7, 2025